Filter
635
Filtered Results: 635
Text search:
molecular
markers
Featured
Recommendations
81
New Publications
123
Language
Document type
No document type
266
Studies & Reports
135
Guidelines
132
Manuals
49
Strategic & Response Plan
27
Training Material
12
Fact sheets
10
Situation Updates
3
Resource Platforms
1
Countries / Regions
India
52
Global
27
Latin America and the Carribbean
17
Kenya
15
Tanzania
14
Western and Central Europe
12
Africa
11
Ethiopia
11
South Africa
9
Nigeria
8
Eastern Europe
8
South–East Asia Region
7
Uganda
7
Sierra Leone
5
Zimbabwe
5
Philippines
5
Ukraine
4
Malawi
4
Asia
4
West and Central Africa
4
Western Pacific Region
4
East and Southern Africa
4
Indonesia
4
Nepal
3
Ghana
3
Cameroon
3
Congo, Democratic Republic of
3
North America
3
Brazil
3
Myanmar / Burma
3
Pakistan
3
Benin
2
Syria
2
Burkina Faso
2
Guinea
2
USA
2
Venezuela
2
Bangladesh
2
Vietnam
2
Namibia
2
Zambia
2
Liberia
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Lesotho
1
China
1
Rwanda
1
Iran
1
Senegal
1
Afghanistan
1
Peru
1
Malaysia
1
Cambodia
1
Jordan
1
Germany
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Gabon
1
Japan
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Sri Lanka
1
Georgia
1
Angola
1
Chad
1
Somalia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
175
Clinical Guidelines
95
Public Health
41
Pharmacy & Technologies
25
Key Resources
17
Women & Child Health
15
Capacity Building
5
Toolboxes
TB
80
AMR
63
COVID-19
62
HIV
41
NTDs
35
Mental Health
33
Rapid Response
32
Malaria
29
Planetary Health
23
NCDs
18
Ebola & Marburg
14
Pharmacy
13
Refugee
8
Specific Hazards
6
Zika
6
Global Health Education
6
Polio
5
Conflict
4
Disability
3
Cholera
3
Caregiver
3
Health Financing Toolbox
3
2.0 Rapid Response
3
Natural Hazards
2
Social Ethics
1
Asylum and Migration Working Paper 1
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
First Global Patient Safety Challenge Clean Care is Safer Care
The WHO Guidelines on Hand Hygiene in Health Care provide health-care workers (HCWs), hospital administrators and health authorities with a thorough review of evidence on hand hygiene in health care and specific recommendations to impro...
This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strategic planning for TB in line with the World Health Organization’s End TB strategy, and the proposed ...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
Monitoring of implementation of collaborative TB/HIV activities and evaluation of impact is critically important. This requires efficient monitoring and evaluation system so as to establish accountability mechanisms between programmes, the population they serve, and donors. The Guide to monitoring a...
"The aim of this book remains as for the first edition, namely to provide an initial point of ready
reference for the identification of hazards and precautions for dangerous chemicals. It is targeted
not only at those in the chemical and process industries, but also anyone likely to work with
che...
This short paper aims to identify key evidence gaps in our knowledge of livestock- and fisheries-linked antimicrobial resistance in the developing world, and to document on-going or planned research initiatives on this topic by key stakeholders.
The antimicrobial resistant (AMR) infections in anima...
WHO Ghana 2022 annual report
recommended
“2022 was an eventful year for the WHO Country Office in Ghana,” says Dr Francis Kasolo, WHO Representative to Ghana.
In 2022, WHO Ghana collaborated with partners to deliver interventions in support of the Government of Ghana's health sector agenda to ensure healthy lives for all towards ach...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-end surveillance. This guidance builds on experience...
